Delivery Order SPE2DB24D8003-SPE2DB25FJUBJ
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a $1,730.82 firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the procurement of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of Dakota Drug, Inc.'s larger $999,999,999.00 indefinite-delivery contract (SPE2DB24D8001) with the DLA Troop Support Medical's ECAT Generation V Program, which enables the company to provide a wide range of pharmaceutical and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,987.39, is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has an ultimate completion date of April 2, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a ceiling value of $3,707.66 and a period of performance through February 24, 2025. The contract is for the delivery of pharmaceutical products, including ZEPBOUND 15 MG/0.5 ML PEN 0.5ML, to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business registered in SAM.gov. The $5,441.71 firm fixed-price contract is for the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.0.5ML pharmaceutical products. The contract has an ultimate completion date of December 24, 2024 and was awarded on December 23, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $6,719.14 firm fixed-price delivery order is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999.00 as part of the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the...
This federal contract award, identified as SPE2DB24D8003 and SPE2DB25FJTJF, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a total ceiling value of $1,491.37. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 25, 2024. Dakota Drug, Inc. is a key supplier of...
This federal contract award, valued at $1,705.26, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a delivery order awarded under DLA's ECAT Generation V Program, a large Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00 that enables Dakota Drug, Inc. to provide a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations....
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZNH, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,828.26 firm fixed-price delivery order is for the supply of 4567886888 ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, which is not set aside, has a ceiling value of $2,980.06 and a period of performance through October 29, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V...
This contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is a firm fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of pharmaceutical products, including prescription medications such as insulin pens, inhalers, anticoagulants, and biologic drugs. The contract, valued at $11,449.29, has an ultimate completion date of September 4, 2024 and is not designated as a set-aside contract. Dakota Drug, Inc. holds a...